Paper - WANFANG MED ONLINE

You Position: Home > Paper

Diagnosis and therapy of hepatogenous diabetes

( views:599, downloads:585 )

Author:: No author available

Journal Title:: WORLD CHINESE JOURNAL OF DIGESTOLOGY

Issue:: 6

DOI:: 10.3969/j.issn.1009-3079.2007.06.014

Key Word:: 肝硬化;糖尿病;胰岛素抵抗;肝源性糖尿病;生长激素;诊断;治疗

Abstract：肝源性糖尿病是指继发于肝实质损害的糖尿病,临床表现以高血糖,葡萄糖耐量减低为特征,其发病率与感染的肝炎病毒类型有关.研究表明肝源性糖尿病患者多存在胰岛素抵抗,血清胰岛素样生长因子(IGF-1)降低及生长激素(GH)水平增高.在诊断与治疗方面与2型糖尿病有所不同,要兼顾肝损害和糖尿病两个方面,本文就此方面加以论述.

Reference

[1]庞翠军,肖常青,彭民浩.与肝移植有关的糖尿病[J].2001,(5).
[2]王毅,宋民喜,蒋海燕,等.肝硬化与肝源性糖尿病关系探讨[J].2003,(8).
[3]韩红梅,朴云峰.肝源性糖尿病发病机制的研究现状[J].2006,(2).
[4]刘春华,马保风,王晓彬.肝源性糖尿病40例临床特点及治疗分析[J].2005,(5).
[5]周喜汉,黄赞松,方文珠.肝硬变糖代谢异常的临床研究[J].2003,(9).
[6]李相成,王学浩.成人活体肝移植的现状[J].2005,(2).
[7]向海平,金荣华,郭新会,等.重组人生长激素对肝炎肝硬化患者生长激素抵抗状况改善的研究[J].2004,(2).
[8]李莉,成军,纪冬.肝源性糖尿病的治疗研究进展[J].2004,(7).
[9]张霞,沈薇,沈鼎明.肝病伴糖代谢异常患者的临床分析[J].2006,(4).
[10]王晶桐,张雪松,刘玉兰,等.肝硬化患者糖代谢异常的临床研究[J].2001,(11).
[11]郭锡明,陈建荣.肝硬化合并糖尿病临床分析[J].2006,(5).
[12]张卫卫,王学清,李岩.肝硬化胰岛素抵抗及血清生长激素水平的研究[J].2002,(10).
[13]郭新会,陈义森,金荣华,等.重组人生长激素治疗肝炎后肝硬化患者低蛋白血症的实验与临床研究[J].2001,(4).
[14]张义红,张义卫.慢性肝病并发肝性糖尿病的临床分析[J].2005,(5).
[15]李伟民,徐魁,彭少华,等.肝源性糖尿病及其胰岛素抵抗临床观察[J].2003,(10).
[16]王华宁,温伟波.肝源性糖尿病临床研究进展[J].2003,(1).
[17]孟晓光,王艳梅,祝彦,等.肝硬化合并糖尿病60例临床分析[J].2002,(1).
[18]刘淑娥,肖丹.肝源性糖尿病临床分析[J].2003,(3).
[19]陈仕珠.注重神经肽在肝硬化营养障碍和糖代谢紊乱中的作用研究[J].2005,(7).
[20]Nakai, T.,Tanimura, H.,Hirokawa, F.,etc.Altered hepatic hemodynamics and improved liver function following intrahepatic vascular infusion of prostaglandin E1[J].1998,33(3).
[21]Sibley SD,Hirsch IB,Palmer JP,etc.Visceral obesity, hepatic lipase activity, and dyslipidemia in type 1 diabetes.[J].2003,88(7).
[22]陈成伟,方晓云,茹素娟,等.肝脏疾病的糖代谢异常研究[J].1995,(5).
[23]A S, Petrides.[Hepatogenic diabetes: pathophysiology, therapeutic options and prognosis].[J].1999,Suppl 1.
[24]Knobler H,Schwartz M,Roman SH,etc.Higher incidence of diabetes in liver transplant recipients with hepatitis C.[J].1998,26(1).
[25]Muller A,Ulrich F,Settmacher U,etc.The impact of liver transplantation on diabetes mellitus.[J].2001,33(1).
[26]S H, Mehta,F L, Brancati,M S, Sulkowski,etc.Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States.[J].2000,133(8).
[27]S, Caronia,K, Taylor,L, Pagliaro,etc.Further evidence for an association between non-insulin-dependent diabetes mellitus and chronic hepatitis C virus infection.[J].1999,30.
[28]M, Brodanová.[Diabetes mellitus and the liver].[J].2001,47(4).
[29]Schattner A,Knobler H,Schihmanter R,etc.Increased risk of type 2 diabetes in noncirrhotic patients with chronic hepatitis C virus infection.[J].2000,75(4).
[30]L, Castera.Steatosis, insulin resistance and fibrosis progression in chronic hepatitis C.[J].2006,52(2).
[31]A R, el-Zayadi,O E, Selim,H, Hamdy,etc.Association of chronic hepatitis C infection and diabetes mellitus.[J].1900,19(4).
[32]王洪涛,陈双,区庆嘉,等.人肝硬化肝细胞生长激素受体及其MRNA的表达变化[J].2002,(3).
[33]M, Pascual,I, Castilla-Cortazar,E, Urdaneta,etc.Altered intestinal transport of amino acids in cirrhotic rats: the effect of insulin-like growth factor-I.[J].2000,279(2).
[34]Jaschke W,Nachbaur K,Vogel W,etc.Transjugular intrahepatic portosystemic shunt (TIPS) augments hyperinsulinemia in patients with cirrhosis.[J].2000,33(6).
[35]Andreas, Barthel,Dieter, Schmoll.Novel concepts in insulin regulation of hepatic gluconeogenesis.[J].2003,285(4).
[36]Baruch Y.The liver: a large endocrine gland (editorial; comment)[J].2000,32(3).
[37]Nilsson F,Edvardsson U,von Lowenhielm HB,etc.Hepatic protein expression of lean mice and obese diabetic mice treated with peroxisome proliferator-activated receptor activators[J].2003,3(4).
[38]Donaghy AJ,Ho KK,Baxter RC,etc.Regulation of the growth hormone receptor/binding protein, insulin-like growth factor ternary complex system in human cirrhosis.[J].2002,36(6).
[39]Ferre P.The biology of peroxisome proliferator-activated receptors: relationship with lipid metabolism and insulin sensitivity.[J].2004,53(Suppl.1).
[40]Picardi A,Gentilucci UV,Afeltra A,etc.Diabetes in chronic liver disease: from old concepts to new evidence.[J].2006,22(4).
[41]Lecube A,Hernandez C,Simo R,etc.High prevalence of glucose abnormalities in patients with hepatitis C virus infection: a multivariate analysis considering the liver injury.[J].2004,27(5).
[42]Abdulkarim AS,Wiesner RH,Zein NN,etc.Prevalence of diabetes mellitus in patients with end-stage liver cirrhosis due to hepatitis C, alcohol, or cholestatic disease.[J].2000,32(2).
[43]IWASAKI YASUHIKO,OHKUBO AKIYUKI,KAJINUMA HIROSHI,etc.Degradation and Secretion of Insulin in Hepatic Cirrhosis[J].1978.
[44]Petersen KF,Krssak M,Navarro V,etc.Contributions of net hepatic glycogenolysis and gluconeogenesis to glucose production in cirrhosis.[J].1999,276(3 Pt.1).
[45]范小玲,刘景院,沈中阳,等.终末期肝病合并糖尿病与肝移植的临床研究[J].2003,(7).
[46]Taneichi H,Kato A,Toshihiro M,etc.Low incidence of vascular complications in patients with diabetes mellitus associated with liver cirrhosis as compared with type 2 diabetes mellitus.[J].2005,205(4).
[47]E, Bonora,C, Coscelli,S, Orioli,etc.Hyperinsulinemia of chronic active hepatitis: impaired insulin removal rather than pancreatic hypersecretion.[J].1984,16.
[48]王亚民.肝性糖尿病内源性胰岛素与C肽测定[J].1995,(4).
[49]Galland-Jos C,Hillon P,Verges B,etc.Risk factors for diabetes mellitus and early insulin resistance in chronic hepatitis C.[J].2001,35(2).
[50]Y T, Kruszynska,P D, Home,N, McIntyre.Relationship between insulin sensitivity, insulin secretion and glucose tolerance in cirrhosis.[J].1991,14.
[51]Henriksen JH,Becker U,Juul A,etc.The acid-labile subunit of the ternary insulin-like growth factor complex in cirrhosis: relation to liver dysfunction (see comments)[J].2000,32(3).
[52]Schmitz F,Reinecke Luthge-A,Schmidt WE,etc.Insulin secretion defects in liver cirrhosis can be reversed by glucagon-like peptide-1.[J].2000,164(1).
[53]Kuo P,Howell CD,Johnson L,etc.Liver transplantation improves cirrhosis-associated impaired oral glucose tolerance.[J].2000,69(11).
[54]D B, Dunger,T D, Cheetham.Growth hormone insulin-like growth factor I axis in insulin-dependent diabetes mellitus.[J].1996,46.